Cognitive impairment in arterial hypertension

Abstract

The article presents a current view on pathogenesis, diagnostic methods and treatment of cognitive disorders in patients with arterial hypertension. Choline alfoscerate drugs, precursors for choline drugs, are characterized. Prescription of the drugs for patients with hypertensive encephalopathy is discussed. Results of clinical trials of the efficacy and safety of the national choline alfoscerate under the brand name Cerepro® are demonstrated.

Keywords

• когнитивные расстройства
• гипертоническая энцефалопатия
• холина альфосцерат
• cognitive disorders
• hypertensive encephalopathy
• choline alfoscerate